Notice: This company has been marked as potentially delisted and may not be actively trading. ARCA biopharma (ABIO) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestTrends ARCA biopharma (NASDAQ:ABIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage30.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.67 MNumber OfInsiders Selling(Last 12 Months)0 Get ABIO Insider Trade Alerts Want to know when executives and insiders are buying or selling ARCA biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABIO Insider Buying and Selling by Quarter Ad Behind the MarketsWhy Trump’s Win Can’t Stop the Coming Crisis - Protect Yourself NowNo matter who sits in the White House over the next four years, a series of events has been triggered that could devastate millions of Americans. These events have caused five major cracks in our economy... That's why I have moved 7-figures of my own money out of the stock market.Watch my emergency briefing here >>> ARCA biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/16/2024Henderson Group Plc JanusMajor ShareholderBuy40$421.92$16,876.80 7/24/2024Henderson Group Plc JanusMajor ShareholderBuy1,318$460.80$607,334.40 7/10/2024Henderson Group Plc JanusMajor ShareholderBuy385$498.24$191,822.40 7/8/2024Henderson Group Plc JanusMajor ShareholderBuy329$498.24$163,920.96 7/5/2024Henderson Group Plc JanusMajor ShareholderBuy196$493.92$96,808.32 7/3/2024Henderson Group Plc JanusMajor ShareholderBuy1,153$511.20$589,413.60 (Data available from 1/1/2013 forward) ABIO Insider Trading Activity - Frequently Asked Questions Who is on ARCA biopharma's Insider Roster? The list of insiders at ARCA biopharma includes Christopher David Ozeroff, Fund Lp Funicular, and Henderson Group Plc Janus. Learn more on insiders at ABIO. What percentage of ARCA biopharma stock is owned by insiders? 30.90% of ARCA biopharma stock is owned by insiders. Learn more on ABIO's insider holdings. Which ARCA biopharma insiders have been buying company stock? The following insider purchased ABIO shares in the last 24 months: Henderson Group Plc Janus ($1,666,176.48). How much insider buying is happening at ARCA biopharma? Insiders have purchased a total of 3,421 ABIO shares in the last 24 months for a total of $1,666,176.48 bought. ARCA biopharma Key ExecutivesMr. Thomas A. Keuer (Age 65)President, COO & Principal Executive Officer Compensation: $400.8kMr. C. Jeffrey Dekker CPA (Age 59)CFO, Treasurer & Company Secretary Compensation: $323.07k More Insider Trading Tools from MarketBeat Related Companies ImmuCell Insider Trades Vaxart Insider Trades Rani Therapeutics Insider Trades Nuvectis Pharma Insider Trades INmune Bio Insider Trades Journey Medical Insider Trades PDS Biotechnology Insider Trades Anixa Biosciences Insider Trades Benitec Biopharma Insider Trades 23andMe Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Here’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock This page (NASDAQ:ABIO) was last updated on 11/12/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredCritical warning from the mountains of CarolinaNvidia CEO Jensen Huang says Big Tech will spend over $1 trillion on data centers. And that still might not...Weiss Ratings | SponsoredCrypto’s FINAL Wealth MomentBitcoin’s final bull market is here. If you missed out on the gains in 2017, or 2021… 2025 stands to be jus...Paradigm Press | SponsoredWall Street’s “Secret” Land Grab33-year Wall Street veteran Dylan Jovine says there is one stock that could soar as high as 1,000% or more wit...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARCA biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABIO Stock Alerts